Literature DB >> 10621854

Immunohistochemical investigation of new suppressor oncogene p130 in oral squamous cell carcinoma.

N Tanaka1, T Odajima, T Nakano, Y Kimijima, S Yamada, K Ogi, G Kohama.   

Abstract

New onco-suppressor gene p130 is one of the Rb family forms and is reported to undergo allelic loss in hepatocellular, prostate, and breast carcinomas; however, no report of p130 has been made in oral tumors. The present study dealt with the expression of p130 and Rb proteins by immunohistochemical staining in oral squamous cell carcinomas (n = 110) and oral mucosa. The site of the carcinomas included tongue (n = 48), gingiva (n = 32), oral floor of the mouth (n = 15), oropharynx (n = 6), buccal mucosa (n = 5), and others (n = 4). Histologically there were 65 well-differentiated carcinomas, 33 moderately differentiated carcinomas, and 12 poorly differentiated ones. Positive staining for p130 and Rb was localized to suprabasal cell layers of the normal oral epithelium. In the oral squamous cell carcinoma, positive staining for p130 and Rb was observed in well-differentiated carcinomas (p130, 66.2%; Rb, 78.5%), more than in poorly differentiated ones (p130, 16.7%; Rb, 50.0%). In immunoelectron microscopic features, p130 protein was localized in the nucleus and mitochondria. The expression of p130 was related to the degree of tumor differentiation as that of Rb. It is suggested that p130 gene may be associated with the development of a wide variety of human malignancies rather than the progression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10621854     DOI: 10.1016/s1368-8375(98)00089-x

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  5 in total

1.  Clinicopathological significance of pRb2/p130 expression in squamous cell carcinoma of the esophagus.

Authors:  T Nozoe; D Korenaga; S Itoh; M Futatsugi; Y Maehara
Journal:  J Cancer Res Clin Oncol       Date:  2002-11-26       Impact factor: 4.553

2.  The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2).

Authors:  Donato Tedesco; Jiri Lukas; Steven I Reed
Journal:  Genes Dev       Date:  2002-11-15       Impact factor: 11.361

3.  Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics.

Authors:  Yan Li; Bo Tian; Jiong Yang; Lei Zhao; Xin Wu; Sheng-Long Ye; Yin-Kun Liu; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-05-14       Impact factor: 4.553

4.  Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status.

Authors:  K Milde-Langosch; C Goemann; C Methner; G Rieck; A M Bamberger; T Löning
Journal:  Br J Cancer       Date:  2001-08-17       Impact factor: 7.640

5.  The expression of retinoblastoma tumor suppressor protein in oral cancers and precancers: A clinicopathological study.

Authors:  Sunila Thomas; Anita Balan; Prabha Balaram
Journal:  Dent Res J (Isfahan)       Date:  2015 Jul-Aug
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.